HSICHenry Schein
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though earnings up +10% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 5.0% now against 5.0% a year earlier.
All from SEC EDGAR, as of Jun 27, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is HSIC growing?
Henry Schein has grown revenue 2.6% a year over three years and 2.7% a year over five, with earnings per share compounding at 0.10%.
Revenue growth, 3-year annual rate · Healthcare median +11% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +2.7%
Revenue growth, 5-year rate · +2.6% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- +0.10%
Earnings per share, 3-year rate · revenue +2.6% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $12.4B
- Revenue FY2022
- $12.6B
- Revenue FY2023
- $12.3B
- Revenue FY2024
- $12.7B
- Revenue FY2025
- $13.2B
Annual income statements as filed with the SEC.